OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation

WALTHAM, Mass., July 23, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced its continued commitment to partnering with pharmaceutical brands to navigate the rapidly changing landscape of state-level consumer privacy legislation while executing comprehensive marketing programs nationwide. This month Florida, Oregon, and Texas, representing just over 16% of the nation’s population, joined California, Colorado, Connecticut, Delaware, Maine, Michigan, Minnesota, Nevada, New York, Utah, Vermont, Virginia and Washington with existing consumer privacy laws. Today, nearly 50% of the US population is covered by some variation of a state-level consumer data protection regulation in addition to national HIPAA laws. That number will grow to 62% in the coming 18 months as privacy laws go into effect in Indiana, Iowa, Kentucky, Maryland, Montana, Nebraska, New Hampshire, New Jersey, and Tennessee. This increase in privacy regulations, that are not analogous state-by-state, will make it more difficult for healthcare marketers to deploy consistent engagement campaigns at scale.